Pure Global

Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity - Trial NCT06405737

Access comprehensive clinical trial information for NCT06405737 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Electronic Science and Technology of China and is currently Recruitment Completed. The study focuses on Healthy. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06405737
Recruitment Completed
drug
Trial Details
ClinicalTrials.gov โ€ข NCT06405737
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity
Oxytocin Modulates the Processing of the Advantageous- and Disadvantageous-inequity

Study Focus

Healthy

Intranasal oxytocin

Interventional

drug

Sponsor & Location

University of Electronic Science and Technology of China

Chengdu, China

Timeline & Enrollment

N/A

Jan 07, 2024

Jun 20, 2024

80 participants

Primary Outcome

Behavioral index: fairness rating scores,Behavioral index: preference rating scores,Neural indices: fMRI-based measures of the outcome presentation stage

Summary

The main aim of the study is to investigate whether intranasal oxytocin modulates
 advantageous- and disadvantageous-inequity and whether oxytocin has similar effects on them
 or not.

ICD-10 Classifications

Obesity
Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Healthy person accompanying sick person
Lifestyle-related condition
Malnutrition

Data Source

ClinicalTrials.gov

NCT06405737

Non-Device Trial